Acute Lymphoblastic Leukaemia-Type Intensive Chemotherapy to Eliminate Minimal Residual Disease After High-Dose Melphalan and Autologous Transplantation in Multiple Myeloma – A Phase I/Ii Feasibility and Tolerance Study of 17 Patients
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1702379
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2000
Authors
Publisher
Springer Science and Business Media LLC